BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12060450)

  • 1. Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer.
    Fanning J; Brown S; Phibbs G; Kramer T; Zaher A
    Int J Gynecol Cancer; 2002; 12(3):286-9. PubMed ID: 12060450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evaluation and lymph node metastasis in surgically staged endometrial carcinoma.
    Pilka R; Marková I; Dusková M; Procházka M; Tozzi M; Kudela M
    Eur J Gynaecol Oncol; 2010; 31(5):530-5. PubMed ID: 21061794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
    Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
    Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma.
    Bell JG; Minnick A; Reid GC; Judis J; Brownell M
    Gynecol Oncol; 1997 Sep; 66(3):388-92. PubMed ID: 9299250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma.
    Sakuragi N; Hareyama H; Todo Y; Yamada H; Yamamoto R; Fujino T; Sagawa T; Fujimoto S
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):311-6. PubMed ID: 10746848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.
    Wakayama A; Kudaka W; Matsumoto H; Aoyama H; Ooyama T; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nishihira K; Kaneshima I; Tamaki T; Yoshimi N; Aoki Y
    Int J Clin Oncol; 2018 Jun; 23(3):532-538. PubMed ID: 29275449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma.
    Ohkouchi T; Sakuragi N; Watari H; Nomura E; Todo Y; Yamada H; Fujimoto S
    Am J Obstet Gynecol; 2002 Aug; 187(2):353-9. PubMed ID: 12193924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
    Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
    Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
    Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
    Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.
    Zhang C; Wang C; Feng W
    Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
    Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
    Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
    Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
    Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis.
    Kokcu A; Kurtoglu E; Celik H; Kefeli M; Tosun M; Onal M
    Asian Pac J Cancer Prev; 2015; 16(13):5331-5. PubMed ID: 26225674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
    Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M
    Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of stromal versican expression in human endometrial cancer.
    Kodama J; Hasengaowa ; Kusumoto T; Seki N; Matsuo T; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
    Ann Oncol; 2007 Feb; 18(2):269-74. PubMed ID: 17065588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study.
    Daniilidou K; Frangou-Plemenou M; Grammatikakis J; Grigoriou O; Vitoratos N; Kondi-Pafiti A
    J BUON; 2013; 18(1):195-201. PubMed ID: 23613406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
    Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
    J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.